Advertisement
UK markets closed
  • FTSE 100

    8,285.71
    +99.36 (+1.21%)
     
  • FTSE 250

    21,356.30
    +471.95 (+2.26%)
     
  • AIM

    779.67
    +6.64 (+0.86%)
     
  • GBP/EUR

    1.1844
    -0.0006 (-0.05%)
     
  • GBP/USD

    1.2873
    +0.0019 (+0.14%)
     
  • Bitcoin GBP

    53,571.21
    +1,059.03 (+2.02%)
     
  • CMC Crypto 200

    1,389.38
    +58.77 (+4.42%)
     
  • S&P 500

    5,459.10
    +59.88 (+1.11%)
     
  • DOW

    40,589.34
    +654.27 (+1.64%)
     
  • CRUDE OIL

    76.44
    -1.84 (-2.35%)
     
  • GOLD FUTURES

    2,385.70
    +32.20 (+1.37%)
     
  • NIKKEI 225

    37,667.41
    -202.10 (-0.53%)
     
  • HANG SENG

    17,021.31
    +16.34 (+0.10%)
     
  • DAX

    18,417.55
    +118.83 (+0.65%)
     
  • CAC 40

    7,517.68
    +90.66 (+1.22%)
     

Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities

ReportLinker
ReportLinker

For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development.

New York, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities" - https://www.reportlinker.com/p06229449/?utm_source=GNW


Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges.With growing interest in personalized and precision medicine, drug development is an area of interest for pharmaceutical players, regulatory bodies, and ordinary people.

The existing scenario of one drug for one disease and all patient populations under the category does not fit anymore.Integrating the latest science and technology will enhance knowledge from traditional drug discovery and take pharmaceutical discoveries to the next level.

Omics provides granular information that was nearly impossible to obtain and understand in the past, offering data on gene expression, patient cohort, and predictive drug response for proposed drugs. Developments in omics and AI also enable the visualization of disease-drug models. Omics allows researchers to study different parameters and combine information gained from genomics, proteomics, and metabolomics, which drive drug development decisions. Other omics technology types such as glycomics and lipidomics are growing, furthering researchers’ understanding of complex, interconnected biological pathways.
Read the full report: https://www.reportlinker.com/p06229449/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001